Learning Objectives:

1. Review outcomes with conventional care of systemic sclerosis (SSc) with lung involvement

2.  Describe the techniques of autologous hematopoietic cell transplantation (HCT)

3.  Examine the evidence of restoration of a normalized immune repertoire in autoimmune disease following HCT

4.  Compare the design and outcomes of recent randomized trials comparing HCT to cyclophosphamide

5.  Formulate criteria for timely referral for HCT in patients with SSc and pulmonary involvement

Speaker Name: 
Dr. Keith Sullivan
Duke South 3rd Floor Conference Room (purple zone)
200 Trent Drive
Durham, NC 27710
United States
Room Number: 
Session date: 
Tuesday, March 1, 2016 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit(s)

Please login or register to take this course.